Acta Medica Philippina, 2022 Pityriasis versicolor is a common fungal infection of the superficial skin layer caused by Malassezia furfur, a normal commensal in the skin. Keratolytic agents are popular, cheap, and readily available over-the-counter treatments for pityriasis versicolor.
Genuino, Rowena Natividad F. +4 more
semanticscholar +5 more sources
Dermatological Effects of Different Keratolytic Agents on Acne Vulgaris
Journal of Clinical Trials, 2016 Acne vulgaris is a chronic inflammatory skin disease; it's one of the most common skin disorders and affects mainly adolescents and young adults. Keratolytic agents are widely used in treatment of acne from several years. In this study we aimed to evaluate and compare the cutaneous response of different keratolytic agents in management of acne vulgaris.
Essa Ajmi Alodeani
semanticscholar +4 more sources
Are topical keratolytic agents needed in the treatment of scalp psoriasis? [PDF]
Dermatology Online Journal, 2014 Topical corticosteroids are the primary treatment for scalp psoriasis. Keratolytic agents are promoted as adjunctive treatments. However, complex treatment regimens may result in poor adherence and outcomes.To evaluate the evidence for the need for use of topical keratolytic agents as opposed to topical corticosteroid monotherapy in the treatment of ...
Shokeen, Divya +3 more
openaire +6 more sources
Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid–Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome: North Central Cancer Treatment Group Study N05C5 [PDF]
Journal of Clinical Oncology, 2010 Purpose Hand-foot syndrome (HFS) is a dose-limiting toxicity of capecitabine for which no effective preventative treatment has been definitively demonstrated. This trial was conducted on the basis of preliminary data that a urea/lactic acid–based topical keratolytic agent (ULABTKA) may prevent HFS.
Sherry L. Wolf +10 more
openaire +5 more sources
Evidenced-based approach facilitates choosing between different topical compounds in acne vulgaris. [PDF]
J Eur Acad Dermatol VenereolJournal of the European Academy of Dermatology and Venereology, Volume 39, Issue 4, Page 711-712, April 2025.
Nikolakis G, Zouboulis CC.
europepmc +2 more sources
Mosaic Darier's Disease: A Case of Unilateral Localized Type I Segmental Darier's Disease. [PDF]
Clin Case RepABSTRACT Darier's disease (DD), also known as Darier‐White disease, is a rare autosomal dominant genodermatosis resulting from mutations in the ATP2A2 gene. It commonly manifests as keratotic papules or plaques in seborrheic areas and is often triggered by heat, sweating, and trauma. A rare mosaic variant, segmental Darier's disease, occurs due to post‐
Al-Soufi L +3 more
europepmc +2 more sources
The treatment of plantar warts with a keratolytic agent and occlusion
Journal of Dermatological Treatment, 1991 In an open, multicentre study, patients with one to ten plantar warts on each foot were randomized prior to treatment for up to 17 weeks to receive either a keratolytic agent alone (Promicid gel) or the same agent covered by an occlusive plaster (Promicid occlusive dressing). A total of 170 patients completed the study.
W. Avrach +6 more
openaire +3 more sources
Moisturizing and Keratolytic Agents [PDF]
, 2012 Raquel Pardavila Riveiro and Celia Posada García
openaire +2 more sources
30% Supramolecular Salicylic Acid Improved Symptoms and Skin Barrier in Papulopustular Rosacea. [PDF]
J Cosmet DermatolABSTRACT Background Rosacea is a chronic skin condition that affects millions of people worldwide, and its management continues to pose a significant challenge in dermatology. Aim In this study, we investigated the efficacy and safety of 30% supramolecular salicylic acid (SSA) as a treatment for papulopustular rosacea, with a particular focus on ...
Wang Z +6 more
europepmc +2 more sources
Psoriasis part 2 – topical treatment, phototherapy and skin care [PDF]
Farmacja Polska, 2023 Psoriasis is a chronic inflammatory disease that requires the selection of appropriate pharmacotherapy and skin care. Topical treatment should be added in pharmacotherapy of every patient with psoriasis.
Ewa Zwierzyńska +2 more
doaj +1 more source